Corona vaccine in India latest updates: India biotech company on Friday said that the interim analysis of the first and second phase trials of its vaccine ‘Kovona’ (Corona vaccine) of Kovid-19 has been successfully completed and now the third on 26 thousand volunteers Phase testing is being started. Also Read – Rahul Gandhi’s attack on BJP on the promise of sharing free vaccine in Bihar, RJD bid – Election bargaining in this too, dirty
The vaccine manufacturer said in a statement, “After successfully completing the interim analysis of the first and second phase clinical trials of the vaccine ‘Kovaxin’, Bharat Biotech is required to conduct the third phase test on 26,000 volunteers at more than 25 centers across India. Approval has been received from the Controller General of Medicine. Also Read – BJP manifesto 2020: If NDA government formed in Bihar, Corona vaccine free, BJP took 11 resolutions …
Bharat Biotech is developing Covaxin in collaboration with the Indian Council of Medical Research and the National Institute of Viruses. Sources said that the Hyderabad-based vaccine manufacturer had sought permission from the Drug Controller General of India on October 2 to begin the third phase of vaccine testing. Also Read – Covid-19 Vaccine Update on 21 October 2020: Corona vaccine will be given to these three crore people in the first phase
In July, the Drug Controller General gave permission to Bharat Biotech to start first and second stage clinical trials of the vaccine.